Events
Start of main content
Rare skin diseases: from clinic to gene and vice versa
Life and Matter Sciences International Symposium October 20-21, 2016 Madrid
General information
Venue: Fundación Ramón Areces, Vitruvio, 5. 28006. Madrid
Limited capacity
- Free registration
Organized by:
Fundación Ramón Areces
Coordinator/s:
Fernando Larcher Laguzzi CIEMAT-Universidad Carlos III de Madrid-IIS Fundación Jiménez Diaz CIBER Rare Diseases. Spain
Deputy Coordinator:
Yolanda Gilaberte Dermatology Unit. Hospital San Jorge Huesca. Director of the magazine Actas Dermo-Sifiliográficas. Spain
- Description
- Programme
Rare hereditary skin diseases, also known as genodermatoses, constitute about 7-8% of rare diseases and together represent a significant part of the pathology and dermatology clinic. Currently the genetic basis of about 400 genodermatoses, mostly monogenic diseases, have been elucidated which allows classification, molecular diagnosis and, to certain extent, understanding their pathogenic mechanisms. As with other types of rare diseases, often the consequences of genodermatosis are devastating for the patient and / or stigmatizing. Genodermatoses are grouped into:
- Disorders of epithelial adhesiveness
- Keratinization / cornification
- Pigmentation
- DNA repair
- Connective tissue
- Ectodermal dysplasias
Despite advances in the field, the main health problems and challenges posed by the variety of genodermatoses are: 1) the difficulty of molecular diagnosis of the disease (mutational analysis), which is essential for proper genetic counseling; 2) characterization of molecular interactions, biomarkers and secondary pathologies associated with the primary genetic defect and 3) the development of safe and effective curative treatments based on the causative molecular defect. While it is impossible to cover all entities, this symposium will present some of the most recent advances in the various large groups of genodermatoses and allow interaction between national and international experts in the subject.
The symposium is divided into 5 sections and a plenary lecture covering both the state of art in the clinical management of this set of diseases as well as current research and future prospects.
Five main topics will be developed:
- Keratinization disorders including developments in research and clinical trials
- Diseases of dermo-epidermal fragility emphasizing its problems in Spain as well as new therapeutic approaches to clinical and pre-clinical level
- DNA rapair diseases with the discovery and characterization of new genes and new lines of research
- Ectodermal dysplasias and the relationship between genotypes and clinical manifestations
- A section of Vascular diseases-cancer of genetic origin and its most relevant clinical aspects
The proposed topics depict the latest developments and the invited speakers are among the leading figures at national and international level in this field.
Thursday, 20
9:30
Welcome and introduction
Federico Mayor Zaragoza
Chairman of the Scientific Council. Fundación Ramón Areces. Spain.
José María Medina
Deputy Chairman of the Scientific Council. Fundación Ramón Areces. Spain.
Fernando Larcher Laguzzi
Coordinator of the Symposium.
Yolanda Gilaberte
Deputy Coordinator of the Symposium.
Pablo Lapunzina
Scientific Director of CIBER de Enfermedades Raras. Spain.
Keratinization disorders
9:45
Netherton syndrome: from murine models to patients
Alain Hovnanian
INSERM UMR 1163. Department of Genetics. Imagine Institute. University Paris Descartes.
Necker Hospital. Paris. France.
10:30
Netherton Syndrome Gene therapy Clinical Trial
Wei Li Di
University College London. Institute of Child Health. Londres. UK.
11:15
What is new in Ichtyosis research?
Heiko Traupe
Department of Dermatology. University Hospital. Muenster. Germany.
12:00
Break
Skin fragility disorders
12:15
Epidermolisis Bullosa en España
María José Escámez
Rocío Maseda
CIEMAT-Universidad Carlos III de Madrid-IIS Fundación Jiménez Díaz. CIBER Rare Diseases and Pediatric Dermatology Service. Hospital Universitario La Paz. Madrid. Spain.
12:45
Epidermolysis Bullosa and Cancer
Andrew South
Department of Dermatology and Cutaneous Biology. Jefferson University, Philadelphia. USA.
13:15
Advances in Dystrophic Epidermolysis Bullosa treatment
Fernando Larcher Laguzzi
CIEMAT-Universidad Carlos III de Madrid-IIS Fundación Jiménez Díaz. Madrid. CIBER Rare Diseases. Madrid. Spain.
14:00
Break
DNA repair disorders
16:00
What is new in Xeroderma Pigmentosum research
Robert Sarkany
St. John's Institute of Dermatology. Londres. UK.
16:45
UV-induced DNA damage repair, transcription and alternative splicing
Alberto Kornblihtt
LFBM-IFIBYNE-UBA-CONICET. Universidad de Buenos Aires. Argentina.
17:30
Nucleotide excision repair genes in human diseases with cancer susceptibility
Jordi Surrallés
Departament of Genetics and Microbiology. Universidad Autónoma de Barcelona.
CIBER Rare Diseases. Spain.
Friday, 21
Ectodermal dysplasias
9:30
Ectodermal dysplasias: Clinical spectrum and genetic correlations
Smail Hadj Rabia
Hôpital Necker Enfants Malades. Paris. France.
10:15
Novel molecular mechanisms of glucocorticoid action: implications for treating skin diseases
Paloma Pérez
Instituto de Biomedicina de Valencia (IBV-CSIC). Spain.
11:00
Break
Keynote conference
11:15
Next generation diagnostics for genodermatoses
John McGrath
King's College London. St John's Institute of Dermatology. Guy's Hospital. London. UK.
Vascular anomalies- cancer
12:15
Congenital vascular anomalies
Eulalia Baselga
Unidad de Dermatología Pediátrica. Hospital de la Santa Creu i Sant Pau. Barcelona. Spain.
12:45
Advances in Familiar Melanoma
Joan Anton Puig
Departament of Biochemistry and Molecular Genetics. Melanoma Unit. Hospital Clínic de Barcelona. CIBER Rare Diseases. Spain.
13:15
Genetic susceptibility in sporadic melanoma
Eduardo Nagore
Department of Dermatology. Instituto Valenciano de Oncología. Valencia. Spain.
-
Activities related
-
Projects related
-
News related
-
Publications related
-
27
Nov
2019
International Symposium Undiagnosed and rare diseases in children and adolescents: Translation to clinic and society Barcelona, Wednesday and Thursday, November 27 and 28, 2019 9:30 hours
-
30
Jan
2020
International Symposium Understanding and reprogramming developmental visual disorders: from anophthalmia to cortical impairments Madrid, Thursday and Friday, 30 and 31 January 2020, 9:30 hours
-
26
Sep
2022
Conference Terapia génica y celular avanzada… Más allá de la última frontera Madrid, Monday, 26 September 2022, 19:00 hours
- Phenotyping of animal models of rare diseases with visual disability 2020 Senior Researcher : Lluís Montoliu José Research Centre or Institution : Centro Nacional de Biotecnología (CNB). CSIC. Madrid
- The neuronal glycine transporter GlyT2 in herplexia: a glycinergic pathology of development 2020 Senior Researcher : Beatriz López Corcuera Research Centre or Institution : Centro de Biología Molecular Severo Ochoa. CSIC - UAM
- Serum markers in patients with congenital melanocytic nevi: clinicopathological and genetic correlation 2020 Senior Researcher : Pedro Redondo Bellón Research Centre or Institution : Clínica Universidad de Navarra. Pamplona
-
-
Eric D. Green: “La genómica debe integrarse en la medicina convencional”
Published on 03/12/2021
End of main content